We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$132M
AUM Growth
+$75.3M
Cap. Flow
+$72.1M
Cap. Flow %
54.67%
Top 10 Hldgs %
4.8%
Holding
478
New
258
Increased
49
Reduced
17
Closed
154

Top Buys

Rank Stock Value
1
VSXY
Victoria's Secret
VSXY
+$912K
2
PI icon
Impinj
PI
+$749K
3
SPWR
SunPower Corporation Common Stock
SPWR
+$745K
4
SBGI icon
Sinclair Inc
SBGI
+$738K
5
FVRR icon
Fiverr
FVRR
+$728K

Top Sells

Rank Stock Value
1
MORN icon
Morningstar
MORN
+$324K
2
STNG icon
Scorpio Tankers
STNG
+$323K
3
RARE icon
Ultragenyx Pharmaceutical
RARE
+$323K
4
ARW icon
Arrow Electronics
ARW
+$323K
5
OSIS icon
OSI Systems
OSIS
+$322K

Sector Composition

Rank Sector Weight
1 Technology 18.6%
2 Industrials 14.38%
3 Healthcare 14.34%
4 Consumer Discretionary 13.9%
5 Real Estate 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SFL icon
276
SFL Corp
SFL
$1.59B
$191K 0.14%
+20,418
New +$185K
ANGO icon
277
AngioDynamics
ANGO
$565M
$188K 0.14%
+18,054
New +$174K
ARLO icon
278
Arlo Technologies
ARLO
$1.51B
$186K 0.14%
17,031
-13,188
-44% -$107K
PATH icon
279
UiPath
PATH
$6.02B
$182K 0.14%
10,991
-306
-3% -$4.91K
MGNI icon
280
Magnite
MGNI
$2.73B
$176K 0.13%
12,877
+392
+3% +$4.36K
PDSB icon
281
PDS Biotechnology
PDSB
$38.7M
$174K 0.13%
+34,606
New +$227K
ASRT
282
DELISTED
Assertio
ASRT
$162K 0.12%
+1,991
New +$185K
NRIX icon
283
Nurix Therapeutics
NRIX
$2.43B
$160K 0.12%
+16,025
New +$163K
LYFT icon
284
Lyft
LYFT
$5.73B
$156K 0.12%
+16,269
New +$156K
TWKS
285
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
$153K 0.12%
+20,305
New +$150K
DAWN
286
DELISTED
Day One Biopharmaceuticals
DAWN
$148K 0.11%
+12,380
New +$162K
HT
287
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$147K 0.11%
+24,064
New +$148K
ADTN icon
288
Adtran
ADTN
$769M
$137K 0.1%
+13,010
New +$129K
HPP
289
Hudson Pacific Properties
HPP
$794M
$135K 0.1%
4,562
-2,370
-34% -$84.7K
COGT icon
290
Cogent Biosciences
COGT
$6.91B
$134K 0.1%
+11,307
New +$130K
ALLO icon
291
Allogene Therapeutics
ALLO
$604M
$134K 0.1%
+26,900
New +$145K
CLVT icon
292
Clarivate
CLVT
$1.36B
$130K 0.1%
+13,608
New +$115K
BB icon
293
BlackBerry
BB
$4.93B
$115K 0.09%
+20,752
New +$101K
FSR
294
DELISTED
Fisker Inc.
FSR
$114K 0.09%
+20,149
New +$116K
OCUL icon
295
Ocular Therapeutix
OCUL
$1.89B
$112K 0.09%
21,777
-697
-3% -$4.14K
MITK icon
296
Mitek Systems
MITK
$768M
$111K 0.08%
+10,201
New +$99.7K
DNOW icon
297
DNOW Inc
DNOW
$2.59B
$110K 0.08%
10,636
-18,402
-63% -$185K
CDXS icon
298
Codexis
CDXS
$141M
$110K 0.08%
+39,194
New +$127K
NWL icon
299
Newell Brands
NWL
$2.2B
$99.2K 0.08%
11,401
+13
+0.1% +$129
SABR icon
300
Sabre
SABR
$704M
$97.6K 0.07%
+30,609
New +$111K
10 11
12
13 14

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q2 2023 Portfolio in Review

As of Q2 2023, Nebula Research & Development held 478 positions worth $132M, up 133% from $56.6M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

Nebula Research & Development deployed $72.1M of net new capital in Q2 2023, opening 258 new positions and adding to 49 existing holdings. Its largest new stake was Victoria's Secret: 36,186 shares worth $631K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was DNOW Inc, an estimated $185K trimmed.

  • Nebula Research & Development's largest Q2 2023 buy was Victoria's Secret: 36,186 shares worth $631K.
  • Nebula Research & Development added most to The Duckhorn Portfolio, Inc. in Q2 2023, an estimated $526K increase.
  • Nebula Research & Development's biggest Q2 2023 reduction was DNOW Inc, cutting an estimated $185K.
  • Nebula Research & Development fully exited Morningstar in Q2 2023, selling an estimated $324K.
  • Nebula Research & Development's ten largest holdings make up 4.8% of its $132M portfolio in Q2 2023.
  • Nebula Research & Development opened 258 new positions and closed 154 in Q2 2023.
  • Nebula Research & Development's portfolio value rose 133% quarter-over-quarter to $132M.

Based on Nebula Research & Development's 13F filing for Q2 2023, filed 14 Aug 2023.